Gamitrinib TPP hexafluorophosphate T11356
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Gamitrinib TPP hexafluorophosphate is a mitochondrial targeted HSP90 inhibitor with anti-cancer activity.�Gamitrinib TPP hexafluorophosphate is a �Gamitrinib (GA) mitochondrial matrix inhibitor.
CAS nr:
1131626-47-5
Purity:
98%
Molecular Weight:
1036,03
SMILES:
F[P-](F)(F)(F)(F)F.O=C(C=C1NC(/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@H](C)[C@H]2O)=O)C(NCCCCCC[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)=C(C[C@H](C[C@@H]2OC)C)C1=O
Formula:
C52H65F6N3O8P2
Pathway:
Metabolism,Cytoskeletal Signaling
Target:
HSP,HSP
